Homeobox A7 promotes esophageal squamous cell carcinoma progression through C‐C motif chemokine ligand 2‐mediated tumor‐associated macrophage recruitment

Author:

Feng Anqi1ORCID,He Lingnan1ORCID,Jiang Jiakai2,Chu Yuan1,Zhang Zehua1,Fang Kang1,Wang Zeyu1,Li Zhaoxing1,Sun Mingchuang1,Zhao Ziying1,Shi Jianing1,Zhang Li3,Chen Tao1,Xu Meidong1

Affiliation:

1. Endoscopy Center, Shanghai East Hospital Tongji University School of Medicine Shanghai China

2. Changzhou Third People's Hospital, Changzhou Medical Center Nanjing Medical University Nanjing China

3. Department of Pathology, Shanghai East Hospital, School of Medicine Tongji University Shanghai China

Abstract

AbstractHomeobox A7 (HOXA7) plays essential roles in multiple malignancies and was reported to be overexpressed in esophageal squamous cell carcinoma (ESCC). However, its functions in the ESCC tumor microenvironment remain to be explored. In this study, we showed that HOXA7 was overexpressed in ESCC among HOXA family members and correlated with tumor‐associated macrophage (TAM) infiltration both in The Cancer Genome Atlas database and ESCC clinical samples. Moreover, transactivation of C‐C motif chemokine ligand 2 (CCL2) by HOXA7 was identified (real‐time quantitative PCR [RT‐qPCR], western blot analysis, ELISA, and ChIP‐qPCR), which was detected to drive chemotaxis and M2 polarization of macrophages both in vitro (Transwell assay) and in vivo (xenograft tumors models). In addition, CCL2 triggers macrophage expression of epidermal growth factor (EGF) (RT‐qPCR and ELISA), which promotes tumor proliferation and metastasis by activating its receptor EGFR. In addition, EGF‐induced ESCC cell proliferation and migration can be abrogated by HOXA7 knockdown (CCK‐8 proliferation assay, EdU fluorescence, and Transwell assay). These results indicate a novel mechanistic role of HOXA7 in the cross‐talk between ESCC and TAMs, which could be an underlying therapeutic target for ESCC.

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3